Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1

被引:26
作者
Jenson, H
McIntosh, K
Pitt, J
Husak, S
Tan, M
Bryson, Y
Easley, K
Shearer, W
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pediat, Div Infect Dis, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Microbiol, Div Infect Dis, San Antonio, TX 78284 USA
[3] Texas Childrens Hosp, Baylor Coll Med, Dept Allergy & Immunol, Houston, TX 77030 USA
[4] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA
[5] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Infect Dis, New York, NY 10032 USA
[6] Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA
[7] Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA
关键词
D O I
10.1086/314764
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The natural history of Epstein-Barr virus (EBV) infection in 556 infants born to 517 human immunodeficiency virus (HIV) type I-infected mothers was studied in a prospective, multicenter, cohort study. HIV-1-infected children had a cumulative EBV infection rate similar to HIV-1-uninfected children at age 3 years (77.8% vs. 84.9%) but had more frequent oropharyngeal EBV shedding (50.4% vs. 28.2%; P <.001), The probability of shedding decreased with longer time from EBV seroconversion and was similar to that of HIV-1-uninfected children 3 years after seroconversion, HIV-1-infected children identified as rapid progressors shed EBV more frequently than nonrapid progressors (69.4% vs. 41.0%; P =.01), HIV-1-infected children with EBV infection had higher mean CD8 cell counts. EBV infection did not have an independent effect on mean CD4 cell counts, percent CD4, IgG levels, HIV-1 RNA levels, lymphadenopathy, hepatomegaly, or splenomegaly, Early EBV infection is common in children born to HIV-1-infected mothers. Children with rapidly progressive HIV-1 disease have more frequent EBV shedding.
引用
收藏
页码:1395 / 1404
页数:10
相关论文
共 49 条
[1]  
ANDIMAN WA, 1985, LANCET, V2, P1390
[2]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[3]  
ASTRIN SM, 1992, ANN NY ACAD SCI, V651, P422
[4]   DETECTION OF EPSTEIN-BARR-VIRUS IN LYMPHOCYTIC INTERSTITIAL PNEUMONIA BY INSITU HYBRIDIZATION [J].
BARBERA, JA ;
HAYASHI, S ;
HEGELE, RG ;
HOGG, JC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (04) :940-946
[5]   EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) ON THE CYTO-TOXIC RESPONSE TO EPSTEIN-BARR VIRUS (EBV) TRANSFORMED LYMPHOCYTE-B [J].
BLUMBERG, RS ;
PARADIS, TJ ;
CRAWFORD, D ;
BYINGTON, RE ;
HIRSCH, MS ;
SCHOOLEY, RT .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1987, 3 (03) :303-315
[6]   GUIDELINE FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING - A REPORT FROM THE NATIONAL-INSTITUTE-OF-ALLERGY-AND-INFECTIOUS-DISEASES, DIVISION OF AIDS [J].
CALVELLI, T ;
DENNY, TN ;
PAXTON, H ;
GELMAN, R ;
KAGAN, J .
CYTOMETRY, 1993, 14 (07) :702-715
[7]   OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR VIRUS BY PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND BY RECIPIENTS OF RENAL HOMOGRAFTS [J].
CHANG, RS ;
LEWIS, JP ;
REYNOLDS, RD ;
SULLIVAN, MJ ;
NEUMAN, J .
ANNALS OF INTERNAL MEDICINE, 1978, 88 (01) :34-40
[8]   A PROSPECTIVE-STUDY OF OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR VIRUS IN RENAL HOMOGRAFT RECIPIENTS [J].
CHATTERJEE, SN ;
CHANG, RS .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1982, 14 (02) :95-98
[9]   SEROEPIDEMIOLOGIC STUDIES OF INFECTIOUS MONONUCLEOSIS WITH EB VIRUS [J].
EVANS, AS ;
NIEDERMA.JC ;
MCCOLLUM, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (21) :1121-&
[10]   FREQUENT OROPHARYNGEAL SHEDDING OF EPSTEIN-BARR-VIRUS IN HOMOSEXUAL MEN DURING EARLY HIV-INFECTION [J].
FERBAS, J ;
RAHMAN, MA ;
KINGSLEY, LA ;
ARMSTRONG, JA ;
HO, M ;
ZHOU, SYJ ;
RINALDO, CR .
AIDS, 1992, 6 (11) :1273-1278